Novartis AG (0QLR) Ratios
Novartis AG Ratios
GB:0QLR's free cash flow for Q3 2026 was $5.10B. For the 2026 fiscal year, GB:0QLR's free cash flow was decreased by $-391.30M and operating cash flow was $5.50B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.12 | 1.04 | 1.16 | 1.29 | 1.51 |
| Quick Ratio | 0.89 | 0.84 | 0.93 | 1.04 | 1.29 |
| Cash Ratio | 0.42 | 0.40 | 0.51 | 0.26 | 0.41 |
| Solvency Ratio | 0.29 | 0.31 | 0.43 | 0.24 | 0.46 |
| Operating Cash Flow Ratio | 0.74 | 0.61 | 0.55 | 0.50 | 0.50 |
| Short-Term Operating Cash Flow Coverage | 3.63 | 2.18 | 2.38 | 2.42 | 2.42 |
| Net Current Asset Value | $ -38.53B | $ -28.42B | $ -22.71B | $ -21.12B | $ -18.25B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.31 | 0.26 | 0.24 | 0.24 |
| Debt-to-Equity Ratio | 0.80 | 0.71 | 0.56 | 0.47 | 0.46 |
| Debt-to-Capital Ratio | 0.45 | 0.42 | 0.36 | 0.32 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.39 | 0.33 | 0.28 | 0.25 | 0.25 |
| Financial Leverage Ratio | 2.51 | 2.32 | 2.14 | 1.98 | 1.95 |
| Debt Service Coverage Ratio | 3.18 | 2.09 | 2.53 | 2.01 | 4.11 |
| Interest Coverage Ratio | 14.38 | 14.46 | 10.65 | 9.24 | 11.11 |
| Debt to Market Cap | 0.13 | 0.15 | 0.12 | 0.13 | 0.15 |
| Interest Debt Per Share | 19.73 | 15.99 | 13.05 | 13.19 | 14.24 |
| Net Debt to EBITDA | 1.07 | 0.96 | 0.71 | 1.39 | 0.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.02% | 75.20% | 73.27% | 73.35% | 73.31% |
| EBIT Margin | 32.17% | 28.32% | 21.38% | 18.35% | 57.57% |
| EBITDA Margin | 41.94% | 40.05% | 39.12% | 33.78% | 70.30% |
| Operating Profit Margin | 31.15% | 28.12% | 20.94% | 18.28% | 22.87% |
| Pretax Profit Margin | 29.99% | 26.37% | 19.55% | 16.51% | 55.78% |
| Net Profit Margin | 25.64% | 23.09% | 31.83% | 16.00% | 54.63% |
| Continuous Operations Profit Margin | 25.61% | 23.08% | 18.37% | 13.92% | 52.09% |
| Net Income Per EBT | 85.52% | 87.54% | 162.78% | 96.91% | 97.92% |
| EBT Per EBIT | 96.26% | 93.78% | 93.39% | 90.32% | 243.93% |
| Return on Assets (ROA) | 12.68% | 11.68% | 14.86% | 5.92% | 18.23% |
| Return on Equity (ROE) | 31.78% | 27.11% | 31.82% | 11.72% | 35.51% |
| Return on Capital Employed (ROCE) | 20.17% | 19.77% | 13.28% | 8.95% | 9.90% |
| Return on Invested Capital (ROIC) | 16.17% | 15.55% | 11.49% | 7.06% | 8.69% |
| Return on Tangible Assets | 24.19% | 23.61% | 29.86% | 12.31% | 35.32% |
| Earnings Yield | 5.46% | 6.06% | 7.04% | 3.53% | 12.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.23 | 5.42 | 4.98 | 4.39 | 4.57 |
| Payables Turnover | 3.20 | 2.81 | 2.53 | 2.25 | 2.11 |
| Inventory Turnover | 2.28 | 2.24 | 2.11 | 1.61 | 1.76 |
| Fixed Asset Turnover | 4.63 | 4.76 | 4.27 | 3.56 | 3.36 |
| Asset Turnover | 0.49 | 0.51 | 0.47 | 0.37 | 0.33 |
| Working Capital Turnover Ratio | 27.26 | 20.27 | 7.56 | 3.66 | 7.25 |
| Cash Conversion Cycle | 116.16 | 100.07 | 102.23 | 147.04 | 114.48 |
| Days of Sales Outstanding | 69.82 | 67.32 | 73.34 | 83.09 | 79.86 |
| Days of Inventory Outstanding | 160.27 | 162.85 | 173.05 | 226.12 | 207.34 |
| Days of Payables Outstanding | 113.92 | 130.10 | 144.16 | 162.17 | 172.72 |
| Operating Cycle | 230.08 | 230.17 | 246.39 | 309.21 | 287.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 10.34 | 8.73 | 6.92 | 6.53 | 6.72 |
| Free Cash Flow Per Share | 9.51 | 6.84 | 5.60 | 5.30 | 5.40 |
| Dividend Paid and CapEx Coverage Ratio | 2.04 | 1.54 | 1.44 | 1.40 | 1.46 |
| Capital Expenditure Coverage Ratio | 12.37 | 4.62 | 5.25 | 5.33 | 5.07 |
| Operating Cash Flow Coverage Ratio | 0.54 | 0.56 | 0.55 | 0.51 | 0.49 |
| Operating Cash Flow to Sales Ratio | 0.35 | 0.34 | 0.31 | 0.33 | 0.34 |
| Free Cash Flow Yield | 6.88% | 7.00% | 5.55% | 5.87% | 6.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.29 | 16.50 | 14.20 | 28.35 | 8.22 |
| Price-to-Sales (P/S) Ratio | 4.69 | 3.81 | 4.52 | 4.54 | 4.49 |
| Price-to-Book (P/B) Ratio | 5.81 | 4.47 | 4.52 | 3.32 | 2.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.54 | 14.28 | 18.02 | 17.05 | 16.31 |
| Price-to-Operating Cash Flow Ratio | 13.37 | 11.19 | 14.59 | 13.85 | 13.09 |
| Price-to-Earnings Growth (PEG) Ratio | 0.66 | -0.99 | 0.12 | -0.40 | 0.04 |
| Enterprise Value Multiple | 12.26 | 10.47 | 12.26 | 14.82 | 6.99 |
| Enterprise Value | 293.64B | 216.89B | 223.89B | 217.56B | 215.96B |
| EV to EBITDA | 12.26 | 10.47 | 12.26 | 14.82 | 6.99 |
| EV to Sales | 5.14 | 4.19 | 4.80 | 5.01 | 4.91 |
| EV to Free Cash Flow | 15.93 | 15.71 | 19.13 | 18.81 | 17.85 |
| EV to Operating Cash Flow | 14.64 | 12.31 | 15.49 | 15.28 | 14.33 |
| Tangible Book Value Per Share | -4.34 | -3.74 | -1.66 | -0.70 | 1.80 |
| Shareholders’ Equity Per Share | 23.78 | 21.83 | 22.33 | 27.21 | 30.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.12 | 0.06 | 0.16 | 0.07 |
| Revenue Per Share | 29.46 | 25.63 | 22.33 | 19.93 | 19.61 |
| Net Income Per Share | 7.56 | 5.92 | 7.11 | 3.19 | 10.71 |
| Tax Burden | 0.86 | 0.88 | 1.63 | 0.97 | 0.98 |
| Interest Burden | 0.93 | 0.93 | 0.91 | 0.90 | 0.97 |
| Research & Development to Revenue | 0.20 | 0.19 | 0.24 | 0.21 | 0.20 |
| SG&A to Revenue | 0.24 | 0.24 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 1.37 | 1.48 | 1.69 | 2.05 | 0.63 |
Currency in USD